NASDAQ · Medical - Devices
NANO-X IMAGING LTD (NNOX) Stock
$0.54
-5.03%
NASDAQ: NNOX
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
New Clinical Study Data, Featuring Nanox.AI Cardiac Solution to Be Presented at SCCT 2026
GlobeNewswire · Jul 7, 2026
Nano X Imaging Ltd (NNOX) Q1 2026 Earnings Call Highlights: Revenue Growth Amidst Financial ...
GuruFocus.com · Jun 25, 2026
Nano-X Imaging Ltd. Q1 2026 Earnings Call Summary
Moby · Jun 25, 2026
Nanox Announces First Quarter 2026 Financial Results and Provides Business Updates
GlobeNewswire · Jun 25, 2026
Nano X Imaging Ltd (NNOX) Q1 2026 Earnings Report Preview: What To Look For
GuruFocus.com · Jun 24, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held0.35%
Institutions Held26.99%
Institutions Float Held27.08%
Peer Comparison
About NANO-X IMAGING LTD
NANO-X IMAGING LTD is led by CEO Erez I. Meltzer, employs 165 people, headquartered in IL, publicly traded since 2020.
NANO-X IMAGING LTD (NNOX) stock trades at $0.54 with a market capitalization of $37.43M. The stock is valued at a price-to-earnings (P/E) ratio of -0.37, price-to-book of 0.61, price-to-sales of 2.83. Over the past 52 weeks the stock has ranged between $0.54 and $4.71, and currently trades 88.5% below its 52-week high.
On profitability, NANO-X IMAGING LTD generates a return on equity (ROE) of -94.35%, return on capital employed of -132.16%, an operating margin of -469.23%, a net profit margin of -747.20%.